Latest News
FDA Approved Genmab's EPKINLY® (epcoritamab-bysp) for Patients with Relapsed or Refractory (R/R) Follicular Lymphoma (FL)
Details >FDA Granted Accelerated Approval of BMS / Mirati's KRAZATI® (adagrasib) in Combo with Cetuximab for Patients with Previously Treated KRAS G12C-Mutated Locally Advanced or Metastatic Colorectal Cancer
Details >FDA Approved Merck's KEYTRUDA® (pembrolizumab) Plus Carboplatin and Paclitaxel as Treatment for Adult Patients With Primary Advanced or Recurrent Endometrial Carcinoma
Details >Report Broken Links
Have you encountered a problem with a URL (link) on this page not working or displaying an error message? Help us fix it!